SmartX has garnered 200 million yuan ($29 million) in its Series B+ and C rounds from Vertex Ventures China, Tianjin Venture Capital and HUA Capital while Brosmed Medical has secured ‘tens of millions of US dollars’ in its Series C funding led by Hillhouse Capital.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com